Cocrystal Pharma is Therapeutic Devices in United States that focus on Cocrystal Pharma Inc business. Founded in 2006. They cover business area such as Cocrystal Pharma Inc, novel antiviral therapeutic, influenza virus, hepatitis C virus, noroviruse, structure-base technology, Nobel Prize-win expertise, class, an investigational, oral, broad-spectrum replication inhibitor, a non-nucleoside inhibitor, NNI, ultra-short therapy.
2006
( 18 years old in 2024 )
Cocrystal Pharma Inc
-
19805 North Creek Parkway
Bothell, WA 98011
United States
Private
Cocrystal Pharma Incnovel antiviral therapeuticinfluenza virushepatitis C virusnorovirusestructure-base technologyNobel Prize-win expertiseclassan investigational, oral, broad-spectrum replication inhibitora non-nucleoside inhibitorNNIultra-short therapy
* We use standard office opening hours in near Cocrystal Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cocrystal Pharma is Therapeutic Devices business from United States that founded in 2006 (18 years old in 2024), Cocrystal Pharma business is focusing on Cocrystal Pharma Inc.
Cocrystal Pharma headquarter office and corporate office address is located in 19805 North Creek Parkway Bothell, WA 98011 United States.
Cocrystal Pharma was founded in United States.
In 2024, Cocrystal Pharma is currently focus on Cocrystal Pharma Inc sector.
Above is snippet of Google Trends for "Cocrystal Pharma Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cocrystal Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
